Current Use of Oral Anticoagulation Therapy in Elderly Patients with Atrial Fibrillation: Results from an Italian Multicenter Prospective Study—The ISNEP Study

Background: Atrial fibrillation (AF) is the most common heart arrhythmia, and its prevalence increases with age. Oral Anticoagulant Therapy (OAT) with non-vitamin K antagonist oral anticoagulants (NOACs) or vitamin K antagonists (VKAs) is essential to avoid thromboembolic events in AF. However, this...

Descripción completa

Detalles Bibliográficos
Autores principales: De Stefano, Francesco, Benassi, Alberto, Cappelletti, Alberto Maria, Donatelli, Francesco, Regazzoli, Damiano, Tolaro, Salvatore, Perego, Francesca, Silverio, Angelo, Scatteia, Alessandra, Guarini, Pasquale, Dellegrottaglie, Santo, Mariani, Simona, Pezzella, Elpidio, Galasso, Gennaro, Caiazza, Francesco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9505177/
https://www.ncbi.nlm.nih.gov/pubmed/36143204
http://dx.doi.org/10.3390/jpm12091419

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9505177/
https://www.ncbi.nlm.nih.gov/pubmed/36143204
http://dx.doi.org/10.3390/jpm12091419

Ejemplares similares